The aquaculture of Senegalese sole (Solea senegalensis) is limited by the poor spawning performance of the F1 generation cultured broodstock. The present study compared the efficiency of two sustained-release delivery systems loaded with gonadotropin-releasing hormone agonist (GnRHa) and a single GnRHa injection on the stimulation of oocyte maturation (OM), sex steroid hormone secretion and spawning.
Introduction
The Senegalese sole (Solea senegalensis) is a common flatfish in the Mediterranean Sea and Southern Atlantic Ocean (Imsland et al., 2003) . In the last decade, there has been growing interest in the aquaculture of Senegalese sole, which has become a priority species for diversification in some European and Mediterranean countries (Imsland et al., 2003; Cañavate et al., 2005) . A number of studies have reported on aspects of the reproduction in captivity of wild-caught Senegalese sole broodstock, including gonadal development, spawning performance and egg quality (Rodríguez, cultured Senegalese sole broodstock by evaluating (a) the resulting GnRHa plasma profile and the induced plasma 17β estradiol (E 2 ) and testosterone (T) levels, (b) their ovarian response, and (c) their spawning kinetics, fecundity and egg quality. and was maintained at 6.5 ± 0.3 ppm. Tanks were supplied with flow-through seawater ACCEPTED MANUSCRIPT developed oocytes at earlier stages of vitellogenesis. All males were spermiating, releasing sperm by abdominal pressure, and the sperm was considered to be of good quality, having >80% motile spermatozoa upon activation with seawater. On the next day (April 19 th 2004, day 0), all fish were anesthetised, weighted and sampled for blood.
Blood was taken from the caudal vasculature using heparinized syringes and placed in ice-cold heparinized tubes. Plasma was obtained by centrifugation (3000 g, 15 min., 4 ºC) and stored at -20 ºC for hormone analysis. Thereafter, fish were treated as follows: (a) In tank 1, Control fish (CNT) were injected with a 0.9% NaCl saline solution (9 females and 10 males); (b) in tank 2 a single GnRHa injection at a dose of 5 µg kg -1 BW 6 females and 5 males) or a single GnRHa injection at a dose of 25 µg kg -1 BW 6 females and 5 males); (c) in tank 3 a GnRHa-loaded implant at a dose of 10 µg kg -1 BW (IMP-10, 6 females and 5 males) or 50 µg kg -1 BW (IMP-50, 6 females and 5 males); in tank 4
GnRHa-loaded microspheres at a dose of 20 µg kg -1 BW (MIC-20, 6 females and 5 males) or 100 µg kg -1 BW (MIC-100, 6 females and 5 males).
For all hormonal treatments, the agonist [D-Ala 6 , Pro 9 Net]-LHRH (Bachem, Switzerland) was used. For injection, GnRHa was dissolved in 0.9% NaCl saline.
Implants were manufactured from Ethylene-Vinyl acetate copolymer (EVAc, Elvax; DuPont Chemical CO., USA) as 2-mm diameter x 3-mm cylinders (Zohar et al., 1990) .
Microspheres were prepared from biodegradable poly-[fatty acid dimmer-sebasic dimmer] (Mylonas et al., 1995) . All three GnRHa treatments were applied in the dorsal musculature. The doses of GnRHa injection, implant and microsphere treatments were based on previous studies with other fishes, including flatfishes (Zohar and Mylonas, 2001 ).
To determine the effect of GnRHa treatment on spawning performance, the occurrence of spawning was checked daily, and the morphology and fertilization of the ACCEPTED MANUSCRIPT produced eggs was examined using a binocular microscope (see further subsection). The effect of the treatments on oocyte diameter frequency and plasma levels of GnRHa, E 2 and T was determined for each fish, thus obtaining data on the effect of the low and high doses of the particular treatment. At 1, 3, 7, 14, 21 and 28 days post-treatment (dpt), females were anesthetised, and the following procedures completed: BW and TL were recorded; stage of maturation classified according to external signs and a blood sample of 0.8 ml was collected. At 7, 14, 21 and 28 dpt ovarian biopsies were also obtained.
Ovarian biopsies
The ovarian biopsy obtained from each individual female was split into two subsamples; one used fresh for immediate observation under the binocular microscope to determine oocyte diameter and morphology, and the other processed for histological analysis using light microscopy. The fresh biopsy sample was placed in a Petri dish and the diameter of a sample of 50 oocytes determined under the binocular microscope, using an ocular micrometer. Then, the sample was dispersed with a clearing solution of ethanol:formalin:acetic acid (6:3:1) and the oocytes classified morphologically in five stages ( , for the E 2 and T ELISA, respectively. The intra-(n=4) and interassay (n=8) coefficients of variation, at 50% of binding, were 5.8% and 6.3% for the E 2 , and 6.1% and 11.3% for the T ELISA.
A specific ELISA developed recently for the GnRHa loaded in the delivery systems (Mylonas et al., 2007) was validated for the quantification of GnRHa in plasma samples of Senegalese sole. The sensitivity of the assay, determined as the lowest detection limit (Bo -2SD), was 51.3 pg ml -1 , whereas the amount of GnRHa that caused 50% of binding (ED50) was 340 pg ml Differences in relative daily fecundity, egg buoyancy and egg size were examined using One-way ANOVA followed by the Student-Newman-Keuls (SNK) multiple comparison procedure, with significance levels of P<0.05. Differences in plasma levels of E 2 , T and GnRHa were examined using Two-way ANOVA followed by the HolmSidak test, with significance levels of P<0.05. Normality and homogeneity of variances were tested by the Kolmogorov-Smirnov and Bartlett methods, respectively. Data are expressed as mean ± standard error of the mean (S.E.M.).
Results

In vivo release kinetics of the GnRHa delivery systems.
An ELISA method was developed and validated for analysis of GnRHa plasma levels in Senegalese sole, using the agonist [D-Ala 6 , Pro
9
-NEthylamide]-LHRH (GnRHa) for the standard curve and for production of the specific antibodies (AbGnRHa). The characteristics of sensitivity, precision, specificity and accuracy of the GnRHa ELISA were carefully checked. The precision of the GnRHa ELISA was tested by means of the intra-and inter-assay coefficient of variations. The specificity of the assay was tested by cross-reaction of the AbGnRHa with GnRHa-free plasma from Senegalese sole, which showed absence of immunoreaction at dilutions lower than 1/10 ( Fig. 2) . The accuracy of the assay was tested by spike-recovery tests, checking also the parallelism between the standard curve and GnRHa-free Senegalese sole plasma spiked with increasing doses of GnRHa. The calculated recovery rate was 78.0 ± 8.6 %.
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Females treated with a GnRHa injection had detectable GnRHa plasma levels at 1 dpt, and at 1 and 3 dpt for the low and high dose, respectively (Fig. 3 ). Females treated with a GnRHa implant maintained detectable and sustained plasma GnRHa levels from 1 to 14 dpt, without any significant differences between the low and high dose. Females treated with GnRHa microspheres exhibited an initial burst of GnRHa at 1 pdt, with the levels declining progressively thereafter, but remaining detectable 7 dpt.
Plasma steroid levels
Control females had similar plasma profiles of E 2 and T during the 4-week experimental period, with initially low levels that increased to peak concentrations at 14 d after the initiation of the experiment, and decreased thereafter (Fig. 4 ). All GnRHa treatments induced significant increases of E 2 and T at 1 dpt relative to Controls (P<0.05). This was maintained until 3 dpt for E 2 . After the initial rise, the plasma E 2 profile in GnRHainjected females resembled that of Controls, whereas both GnRHa-implant and GnRHamicrosphere treated females showed a gradual decrease. Also, after 7 dpt, plasma T levels in all GnRHa-treated groups resembled that of Controls.
Induction of oocyte maturation and spawning
Control females did not show clear variations in oocyte size distribution during the 4 week experimental period, with most of the population below 650 µm in diameter, consisting of oocytes at various stages of vitellogenesis and maturation (Fig. 5) . Hydrated oocytes were only found in one female at 14 dpt and two females at 21 and 28 dpt., but always at low incidence (< 5% of total). In general, females treated with GnRHa by injection showed a similar oocyte size distribution to Controls. However, 4 females of the low dose GnRHa injection group possessed hydrated oocytes at weeks 2 and 3 pt, coincident with the recorded spawning events.
In contrast, treatment with both GnRHa implants and microspheres (high and low doses) caused a clear differentiation of the oocyte size distribution relative to Controls (Fig. 5) . Beginning one week after treatment and throughout the experiment, postvitellogenic and hydrated oocytes (diameter >650 µm) were present. All females from these groups appeared to have spawned at least once, as evidenced by the presence of ovulated eggs in their biopsies and a high volume of ovarian fluid. Daily fecundities decreased at 28 dpt in GnRHa-implanted females and 21 dpt in females treated with GnRHa-microspheres. At this time, there were still significant numbers of hydrated oocytes in the biopsies, together with apoptotic oocytes that were very abundant at 28 dpt in the fish treated with GnRHa microspheres. Fish from the Control tank showed sporadic spawning of low fecundity in May and June (Fig. 6 ). The GnRHa injection treatment caused no apparent effect on spawning, with some late spawning detected in May-June. In contrast, both sustained-release GnRHa delivery systems induced spawning from 4 and 6 dpt, respectively. In both cases, a clear rhythm of daily spawning was established until day 26-28 pt, then continuing with sporadic spawning during the next month presumably not under the direct influence of the GnRHa treatments.
All three GnRHa treatments improved spawning performance with respect to Controls (Table 2 ). All treatments increased the number of spawnings, the spawning period and daily fecundity, with respect to Controls. Total fecundity was increased 4-fold by the GnRHa injection and 22-and 15-fold by the GnRHa implant and microsphere treatments, respectively, with respect to Controls. Egg buoyancy was similar in GnRHa treated fish, but all eggs were unfertilized, based on the absence of embryos 24 h after spawning. No differences in mean egg diameter were found among treatments (Table 2) . However, a ACCEPTED MANUSCRIPT significant decrease in egg size was observed in the GnRHa implanted fish along the spawning period (P <0.01, Fig. 7 ). This correlation between decreasing egg size and the date of spawning became highly significant when considering the first 4 weeks after treatment, the period of induced spawning under direct GnRHa influence, were the fish treated with
GnRHa microspheres also exhibited a significant reduction of egg size with time. There were no significant changes in egg diameter during the experiment in spawns from the Control or GnRHa-injected tanks.
Discussion
Currently, the emerging aquaculture industry for the Senegalese sole is entirely dependent on the spawning of wild-caught individuals (Dinis et al., 1999; Imsland et al., 2003; Howell et al., 2006) . The expansion and optimization of this industry requires the development of protocols for the control of reproduction of cultured broodstock (F1 generation). The present work studied the efficacy of three GnRHa-based spawning induction therapies on cultured Senegalese sole, by comparing injection with two sustained-release delivery systems (Mylonas and Zohar, 2001) . This is the first report on in vivo release kinetics of GnRHa treatments in a warm-water flatfish and the results may be applicable to related species. The ELISA developed for this purpose showed optimal characteristics of precision, accuracy and specificity, and its sensitivity was comparable to previously developed GnRHa radioimmunoassays, which were 62 pg ml -1 (Sherwood et al., 1988) and 50 pg ml -1 (Mylonas et al., 1997a) . The exogenously administered GnRHa in Senegalese sole was cleared from the circulation at different rates, depending on the administration method, and was 3 d for injection, 14 d for microspheres and 21 d for implants. This pharmacokinetic information is of interest in determining the duration of the GnRHa in vivo action and the adequate timing for potential repetitive treatments (Mylonas et al., 2004) . However, the clearance of exogenous GnRHa from the blood may vary due to administration method and dose, but also due to water temperature and the metabolism of the species ( and became undetectable after 7 d (Mylonas and Zohar, 2001) . A higher dose for the microspheres was used compared to the implants, since microspheres were expected to result in a longer release duration compared to the implants (8 vs 4 weeks) (Mylonas et al., 1995) . Therefore, in order to achieve similar plasma GnRHa levels for at least the first 4 weeks of the study, a twice as high dose was used. However, the opposite was observed, with microspheres releasing for a much less period of time.
Plasma levels of both E2 and T increased after all three GnRHa treatments, indicating stimulation of gonadotropin-mediated sex steroid secretion by the gonad.
Previous studies with other fishes reported a similar sex steroid increase soon after GnRHa treatment. For example, female yellowtail flounder treated with GnRHa implants or microspheres showed increased plasma E2 levels 4 dpt (Larsson et al.,
1997). In stripped trumpeter (Latris lineata), GnRHa implantation increased T and E2
ACCEPTED MANUSCRIPT levels at days 1 and 2, respectively (Morehead et al., 1998), whereas in captive white bass (Morone chrysops) both E2 and T plasma levels peaked 18 h after GnRHa treatment (Mylonas et al., 1997) . After the initial GnRHa induced rise of sex steroid secretion, the plasma levels of E2 decreased steadily in Senegalese sole treated with both GnRHa implants and microspheres, but remained elevated in controls and GnRHa injected fish. This could be related to the observed differences in spawning between groups. A study performed in the North Sea plaice (Pleuronectes platessa), showed that treatment with a GnRHa implant caused an initial rise of plasma T and E2 levels 4 dpt and a sharp decrease thereafter, which was correlated with a concomitant increase of plasma progestogens and the stimulation of OM (Scott et al., 1999) . In the present study, the decreased plasma levels of E2 in Senegalese sole treated with implants and microspheres could be correlated with the steroidogenic shift to the production of progestogens (Senthilkumaran et al., 2004) , related to the observed stimulation of OM and spawning in these group of fish, as compared to controls and GnRHa injected Senegalese sole.
Saline-treated Senegalese sole in the present study produced some spawns of poor quality in May and early June. This was expected, since spawning of cultured breeders at our facilities coincides with the main natural spawning period of wild-caught Senegalese sole broodstock (Guzmán et al., 2008) . Egg production by cultured broodstock is always less frequent and of lower fecundity than that of wild breeders. In the present study, the fecundity of the Controls was 150-fold lower than reported for wildcaught broodstocks (Anguis and Cañavate, 2005) , reflecting the fact that only one third of females ovulated, producing small numbers of hydrated oocytes (<5% of the total oocyte population).
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In contrast, GnRHa treatments induced significantly more spawning events.
Although a single GnRHa injection was relatively ineffective, both implant and microspheres induced daily spawning for a period of around 3 weeks. Injected fish showed a slightly higher fecundity than Controls, although this might not have been caused directly by the hormonal treatment, because the first spawning was observed at 21 dpt, which was 17 d after exogenously administered GnRHa had disappeared from the bloodstream in these fish. Also, the observation of the ovarian biopsies in the In spite of the success in inducing OM, ovulation and spawning by sustained release GnRHa treatments, there was a complete failure of fertilization, as observed earlier in both GnRHa-induced and spontaneous spawning of cultured Senegalese sole (Agulleiro et al., 2006; Guzmán et al., 2008) . One possible explanation for this result would be the absence or alteration of courtship and spawning behaviour of the cultured breeders, a critical process for successful reproduction. In greenback flounder and southern flounder, spawning occurs when a male swims close to the female, with genital pores together, and lifts the female toward the water surface, at which time eggs and sperm are released simultaneously (Smith et al., 1999; Pankhurst and Fitzgibbon, 2006) . In common sole, a similar behaviour has been described, in which pairs formed on the tank floor swam together towards the water surface where the gamete release took place simultaneously (Baynes et al., 1994) . Recent video-recording studies in cultured
Senegalese sole have shown that in tanks containing GnRHa implanted fish, egg release might take place in the absence of any courtship or spawning behaviour (N. Duncan, IRTA, Spain, personal communication). In other flatfishes, such as the flounder (Paralichthys orbignyanus) (Bambill et al., 2006) or summer flounder (Watanabe et al., 1998; Watanabe and Carroll, 2001) , the high variability in egg fertilization success has been attributed to a low participation of males in spawning events. Another factor influencing fertilization success could be the inhibition or delayed spawning after ovulation, leading to overripening of the eggs (Berlinsky et al., 1996) , a process that can be especially rapid in warm-water species (Bromage et al., 1994; Zohar and Mylonas, 2001 ).
There was a reduction of the size of the eggs spawned after GnRHa implant or microsphere treatment as spawning progressed. Variations in egg diameter during the natural spawning season have been previously described in wild Senegalese sole (Dinis et al., 1999) , in its congener common sole (Baynes et al., 1993) and in other multiplespawning fishes (Hinckey, 1990; McEvoy and McEvoy, 1991; Kjesbu et al., 1996) . In both GnRHa-treated and untreated turbot, egg size decreased concomitantly with egg batch number, but without any differences in egg quality (Mugnier et al., 2000) . Also, in GnRHa-treated European sea bass a reduction in egg size was observed in consecutive spawns, but without any variations in egg quality (Forniés et al., 2001 ).
The underlying reason for decreased egg size along the spawning season in many fishes is unclear.
In conclusion, the present results indicated that cultured Senegalese sole female breeders may be induced to undergo OM and spawn spontaneously in a daily rhythm after treatment with sustained administration of GnRHa, through implants or microspheres. However, such hormonal treatment is not sufficient to solve the problem of complete lack of egg fertilization observed in cultured (F1 generation) broodstock, which needs to be investigated further, focusing on breeding behaviour and/or male fish function. GnRHa (ng ml-1) 
